# reload+after+2024-01-21 06:47:48.000510
address1§64 Sidney Street
city§Cambridge
state§MA
zip§02139
country§United States
phone§617 588 5555
fax§617 588 5554
website§https://vcel.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
fullTimeEmployees§305
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Dominick C. Colangelo Esq.', 'age': 59, 'title': 'CEO, President & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1419764, 'exercisedValue': 0, 'unexercisedValue': 22916596}, {'maxAge': 1, 'name': 'Mr. Joseph Anthony Mara Jr.', 'age': 47, 'title': 'CFO & Treasurer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 673439, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Halpin', 'age': 62, 'title': 'Chief Operating Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 718238, 'exercisedValue': 0, 'unexercisedValue': 1736759}, {'maxAge': 1, 'name': 'Mr. Sean C. Flynn', 'age': 49, 'title': 'Senior VP, General Counsel & Secretary', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 593238, 'exercisedValue': 0, 'unexercisedValue': 933325}, {'maxAge': 1, 'name': 'Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.', 'age': 61, 'title': 'Chief Medical Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 615240, 'exercisedValue': 523700, 'unexercisedValue': 913991}, {'maxAge': 1, 'name': 'Mr. Jonathan  Siegal', 'title': 'Principal Accounting Officer, VP & Corporate Controller', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eric  Burns', 'title': 'Vice President of Finance & Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick J. Fowler', 'title': 'Senior Vice President of Corporate Development & Strategy', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick  Helfrich', 'title': 'Vice President of Marketing & Commercial Strategy', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Heidi  Hassen', 'title': 'Senior Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§3
compensationRisk§5
shareHolderRightsRisk§4
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.645
priceToSalesTrailing12Months§8.3795
currency§USD
dateShortInterest§1702598400
forwardEps§0.08
exchange§NGM
quoteType§EQUITY
shortName§Vericel Corporation
longName§Vericel Corporation
firstTradeDateEpochUtc§855066600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f46775e8-0ff4-3560-a86f-60297a1259db
gmtOffSetMilliseconds§-18000000
targetHighPrice§45.0
targetLowPrice§39.0
targetMeanPrice§42.58
targetMedianPrice§43.0
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§6
quickRatio§4.036
grossMargins§0.67661005
ebitdaMargins§-0.04637
trailingPegRatio§None
